Proteomic analyses of host and pathogen responses during bovine mastitis

Journal of Mammary Gland Biology and Neoplasia

Volumn 16, Issue 4, 2011, Pages 323-338

  Boehmer, Jamie L ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Biomarkers; Mastitis; Mastitis pathogens; Milk proteins; Proteomics

Indexed keywords

BIOLOGICAL MARKER;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; FEMALE; HOST RESISTANCE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MASTITIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MILK; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; STAPHYLOCOCCUS AUREUS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNINDEXED SEQUENCE;

ANIMALS; BIOLOGICAL MARKERS; CATTLE; FEMALE; HOST-PATHOGEN INTERACTIONS; MASTITIS, BOVINE; MILK; MILK PROTEINS; PROTEOME; PROTEOMICS;

EID: 84855691564     PISSN: 10833021     EISSN: 15737039     Source Type: Journal    
DOI: 10.1007/s10911-011-9229-x     Document Type: Article

References (84)

1. Taba M, Kinney J, Kim AS, Giannobile WV. Diagnostic biomarkers for oral and periodontal diseases. Dent Clin North Am. 2005;49:551-6.
2. Kijanka G, Murphy D. Protein arrays as tools for serum autoantibody marker discovery in cancer. J Proteomics. 2009; Epub Feb 28, 2009.
3. Boenisch O, Chandraker A. Predictive biomarkers of renal allograft failure. Expert Opinion Med Diag. 2008;2:1279-90.
4. Sakurada A, Tsao MS. Predictive biomarkers for EGFR therapy. Invest Drugs. 2009;12:34-8.
5. Bose S, Evans H, Lantzy L, Scharre K, Youssef E. p16INK4A is a surrogate biomarker for a subset of human papilloma virusassociated dysplasias of the uterine cervix as determined on the Pap smear. Diag Cytopath. 2004;32:21-4. (Pubitemid 40024069)
6. LaBaer J. So you want to look for biomarkers. J Protoeme Res. 2005;4:1053-9.
7. Issaq HJ, Blonder J. Electrophoresis and liquid chromatography/ tandem mass spectrometry in disease biomarker discovery. J Chromatogr B. 2009;877:1222-8.
8. Mann M, Hendrickson RC, Pandey A. Analysis of proteins and proteomes by mass spectrometry. Annu Rev Biochem. 2001;70:437-73. (Pubitemid 32662217)
9. Colantonio DA, Chan DW. The clinical application of proteomics. Clinica Chimica Acata. 2005;357:151-8. (Pubitemid 40884594)
10. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotopecoded affinity tags Nat. Biotechnol. 1999;17:994-9. (Pubitemid 29474856)
11. Ideker T, Thorsson V, Ranish JA, Christmas R, Buhler J, Eng JK, et al. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science. 2001;255:929-34. (Pubitemid 32422490)
12. Griffin TJ, Gygi SP, Ideker T, Rist B, Eng J, Hood L, et al. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Prot. 2002;1:323-33.
13. Tian Q, Stephaniants SB, Mao M, Weng L, Feetham MC, Doyle MJ, et al. Integrated genomic and proteomic analyses of gene expression in mammalian cells. Mol Cell Prot. 2004;3:960-9.
14. Bannerman DD. Pathogen-dependent induction of cytokines and other soluble inflammatory mediators during intramammary infection of dairy cows. J Anim Sci. 2009;87(13 SUPPL.):10-25.
15. Hogan JS, Smith KL, Hoblet KH, Schoenberger PS, Todhunter DA, Hueston WD, et al. Field survey of mastitis in low somatic cell count herds. J Dairy Sci. 1989;72:1547-56.
16. Erskine RJ. Antimicrobial use in bovine mastitis. In: Prescott JF, Baggot JD, Walker RD, editors. Antimicrobial therapy in veterinary medicine. 3rd ed. Ames: Iowa State Univ. Press; 2000. p. 712-34.
17. Paape MJ, Lilius EM, Wiitanen PA, Kontio MP, Miller RH. Intramammary defense against infections induced by Escherichia coli in cows. Am J Vet Res. 1996;57:477-82. (Pubitemid 126575857)
18. Lee J-W, Paape MJ, Elsasser TH, Zhao X. Elevated milk soluble CD14 in bovine mammary glands challenged with Escherichia coli lipopolysaccharide. J Dairy Sci. 2003;86:2382-9. (Pubitemid 39001259)
19. Anderson KL. Therapy for acute coliform mastitis. Comp Contin Educ Pract Vet. 1989;11:1125-33.
20. Lohuis JACM, van Werven T, Brand A, van Miert ASJPAM, Ludwig B, Rohde E, et al. Pharmacodynamics and pharmacokinetics of carprofen, a non-steroidal anti-inflammatory drug, in healthy cows and cows with Escherichia coli endotoxin-indiced mastitis. J Vet Pharmacol Ther. 1991;14:219-29.
21. Vangroenweghe F, Duchateau L, Boutet P, Lekeux P, Rainard P, Paape MJ, et al. Effect of carprofen treatment following experimentally induced Escherichia coli mastitis in primiparous cows. J Dairy Sci. 2005;88:2361-76. (Pubitemid 41051039)
22. O'Donnell R, Holland JW, Deeth HC, Alewood P. Review: Milk proteomics. Int Dairy J. 2004;14:1013-23.
23. Hogarth CJ, Fitzpatrick JL, Nolan AM, Young FJ, Pitt A, Eckersall PD. Differential protein composition of bovine whey: A comparison of whey from healthy animals and from those with clinical mastitis. Proteomics. 2004;4(7):2094-100. (Pubitemid 38880374)
24. Smolenski G, Haines S, Kwan FYS, Bond J, Farr V, Davis SR, et al. Characterization of host defense proteins in milk using a proteomic approach. J Prot Res. 2007;6(1):207-15. (Pubitemid 46173673)
25. Boehmer JL, Bannerman DD, Shefcheck KJ, Ward JL. Proteomic analysis of differentially expressed proteins in bovine milk during experimentally induced Escherichia coli mastitis. J Dairy Sci. 2008;91(11):4206-18.
26. Boehmer JL, Ward JL, Peters RR, Shefcheck KJ, McFarland MA, Bannerman DD. Proteomic analysis of the temporal expression of bovine milk proteins during coliform mastitis and label-free relative quantification. J Dairy Sci. 2010;93(2):593-603.
27. Boehmer JL, DeGrasse JA, McFarland MA, Tall EA, Shefcheck KJ, Ward JL, et al. The proteomic advantage: Label- free quantification of proteins expressed in bovine milk during experimentally induced coliform mastitis. Vet Immunol Immunopath. 2010. doi:10.1016/j.vetimm.2010.10.004.
28. Danielsen M, Codrea MC, Ingvartsen KL, Friggens NC, Bendixen E, Røntved CM. Quantitative milk proteomics-Host responses to lipopolysaccharide-mediated inflammation of bovine mammary gland. Proteomics. 2010;10:2240-9.
29. Baeker R, Haebel S, Schlatterer K, Schlatterer B. Lipocalin-type prostaglandin D synthase in milk: A new biomarker for bovine mastitis. Prostaglandins Other Lipid Mediat. 2002;67:75-88. (Pubitemid 34082714)
30. Larsen LB, Hiz K, Jørgensen ALW, Møller HS, Wellnitz O, Bruckmaier RM, et al. Proteomic and peptidomic study of proteolysis in quarter milk after infusion with lipoteichic acid from Staphylococcus aureus. J Dairy Sci. 2010;93:5613-26.
31. Hettinga K, van Valenberg H, de Vries S, Boeren S, van Hooijdonk T, van Arendonk J, et al. The host defense proteome of human and bovine milk. PLoS ONE. 2011;6: E19433. 1-8.
32. Beddek AJ, Rawson P, Peng L, Snell R, Lehnert K, Ward HE, et al. Profiling the metabolic proteome of bovine mammary tissue. Proteomics. 2008;8:1502-15. (Pubitemid 351518557)
33. Peng L, Rawson P, McLaughlin D, Lehnert K, Snell R, Jordan TW. Proteomic analysis of microsomes from lactating bovine mammary gland. J Prot Res. 2008;7:1427-32.
34. Taverna F, Negri A, Piccinini R, Zecconi A, Nonnis S, Ronchi S, et al. Characterization of cell wall associated proteins of a Staphylococcus aureus isolated from bovine mastitis case by a proteomic approach. Vet Microbiol. 2007;199:240-7. (Pubitemid 46027461)
35. Tedeschi G, Taverna F, Negri A, Piccinini R, Nonnis S, Ronchi S, et al. Serological proteome analysis of Staphylococcus aureus isolated from sub-clinical mastitis. Vet Microbiol. 2009;134:388-91.
36. Lippolis JD, Bayles DD, Reinhardt TA. Proteomic changes in Escherichia coli when grown in fresk milk versus laboratory media. J Proteome Res. 2009;8:149-58.
37. Wolf C, Kusch H, Monecke S, Albrecht D, Holtfreter S, von Eiff C, et al. Genomic and proeomic characterization of Staphylococcus aureus mastitis isolates of bovine origin. 2011. doi:10.1002/ pmic.201000698.
38. Reid GE, McLuckey SA. 'Top-down' protein characterization via tandem mass spectrometry. J Mass Spectrom. 2002;37:663-75. (Pubitemid 34830804)
39. Macek B, Waanders LF, Olsen JV, Mann M. Top-down protein sequencing and MS3 on a hybrid linear quadrupole ion traporbitrap mass spectrometer. Mol Cell Prot. 2006;5:949-58. (Pubitemid 43792803)
40. Van den Bergh G, Arckens L. Recent advances in 2D electrophoresis: An array of possibilities. Expert Rev Proteomics. 2005;2:243-52. (Pubitemid 40529862)
41. Fitzgerald MC, Parr GR, Smith LM. Basic matrices for the matrixassisted laser desorption/ionization mass spectrometry of proteins and oligonucleotides. Anal Chem. 1993;65:3204-11. (Pubitemid 24015472)
42. Dass C. Principles and practices of biological mass spectrometry. Wiley Interscience; 2001.
43. Kaufmann R, Kirsch D, Spengler B. Sequencing of peptides in a time-of-flight MS: Evaluation of post source decay following matrix-assisted laser desorption ionization (MALDI). Int J Mass Spec Ion Proc. 1994;131:355-85.
44. Medzihradszky KF, Campbell JM, Baldwin MA, Falick AM, Juhasz P, Vestal ML, et al. The characteristics of peptide collisioninduced dissociation using a high performance MALDI-TOF/TOF tandem mass spectrometer. Anal Chem. 2000;72:552-8. (Pubitemid 33595291)
45. Washburn MP, Wolters D, Yates J. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotech. 2001;19:242-7. (Pubitemid 32220565)
46. Jensen ON, Wilm M, Shevchenko A, Mann M. Sample preparation methods for mass spectrometry peptide mapping directly from 2-DE gels. Methods Mol Biol. 1999;112:513-30.
47. Wilm M, Mann M. Analytical properties of the nanoelectrospray ion source. Anal Chem. 1996;68:1-8.
48. Syka JE, Coon JJ, Schroeder MJ, Shabanowitz J, Hunt DF. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc Nat Acad Sci. 2004;101:9528-33. (Pubitemid 38869270)
49. Anderson NL, Anderson NG. The human plasma proteome: History, character, and diagnostic prospects. Mol Cell Prot. 2002;1:845-67.
50. Garbis S, Lubec G, Fountoulakis M. Limitations of current proteomic technologies. J Chromatogr A. 2005;1077:1-18.
51. Bandow JE. Comparison of protein enrichment strategies for proteome analysis of plasma. Proteomics. 2010;10:1416-25.
52. Roe MR, Griffin TJ. Gel-free mass spectrometry-based high throughput proteomics: Tools for studying biological response of proteins and proteomes. Proteomics. 2006;6:4678-87. (Pubitemid 44369048)
53. Fenselau C. A review of quantitative methods for proteomic studies. J Chromatogr B. 2007;855:14-20. (Pubitemid 47077716)
54. Mueller LN, Brusniak M-Y, Mani DR, Aebersold R. An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data. J Prot Res. 2008;7:51-61. (Pubitemid 351171115)
55. Simpson K, Whetton AD, Dive C. Quantitative mass spectrometry-based techniques for clinical use: Biomarker identification and quantification. J Chromatogr B. 2009;877:1240-9.
56. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Prot. 2002;1:376-86.
57. Yao X, Afonso C, Fenselau C. Dissection of proteolytic 18O labeling: Endoprotease-catalyzed 16O-to-18O exchange of truncated peptide substrates. J Prot Res. 2003;2:147-52. (Pubitemid 37099050)
58. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Prot. 2004;3:1154-69.
59. Chakraborty A, Regnier FE. Global internal standard technology for comparative proteomics. J Chromatogr A. 2002;949:173-84. (Pubitemid 34183425)
60. Reinhardt TA, Lippolis JD. Developmental changes in the milk fat globule membrane proteome during the transition from colostrums to milk. J Dairy Sci. 2008;91:2307-18. (Pubitemid 351807974)
61. Old WM, Meyer-Arendt K, Aveline-Wolf L, Pierce KG, Mendoza A, Sevinsky JR, et al. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Prot. 2005;4:1487-502. (Pubitemid 41555475)
62. Liu H, Sadygov RG, Yates III JR. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem. 2004;76:4193-201. (Pubitemid 38943698)
63. Zybailov B, Coleman MK, Florens L, Washburn MP. Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling. Anal Chem. 2005;77:6218-24. (Pubitemid 41436955)
64. Shimazaki K, Tezima S, Sukegawa K. Analysis of bovine whey protein components by two-dimensional electrophoresis. Agric Biol Chem. 1983;47:2909-12.
65. Holt DL, Zeece MG. Two-dimensional electrophoresis of bovine milk proteins. J Dairy Sci. 1988;71:2044-50.
66. Bobe G, Beitz DC, Freeman AE, Lindberg GL. Separation and quantification of bovine milk proteins by reversed-phase highperformance liquid chromatography. J Agric Food Chem. 1998;46:458-63. (Pubitemid 128488408)
67. Léonil J, Mollé D, Gaucheron F, Arpino P, Guénot P, Maubois JL. Analysis of major bovine milk proteins by on-line highperformance liquid chromatography and electrospray ionizationmass spectrometry. Lait. 1995;75:193-210.
68. Hiss S, Mielenz M, Bruckmaier M, Sauerwein H. Haptoglobin concentrations in blood and milk after endotoxin challenge and quantification of mammary Hp mRNA expression. J Dairy Sci. 2004;87:3778-84. (Pubitemid 39474550)
69. Bannerman DD, Paape MJ, Lee J-W, Zhao X, Hope JC, Rainard P. Escherichia coli and Staphylococcus aureus elicit differential innate immune responses following intramammary infection. Clin Diagn Lab Immunol. 2004;11:463-72. (Pubitemid 38661412)
70. Eckersall PD, Young FJ, McComb C, Hogarth CJ, Safi S, Weber A, et al. Acute phase proteins in serum and milk from dairy cows with clinical mastitis. Vet Rec. 2001;148:35-41. (Pubitemid 33703171)
71. Burger D, Dayer J-M. High-density lipoprotein-associated apolipoprotein A-I: The missing link between infection and chronic inflammation? Autoimmun Rev. 2002;1:111-7. (Pubitemid 38367434)
72. Liao XL, Lou B, Ma J, Wu MP. Neutrophils activation can be diminished by apolipoprotein A-I. Life Sci. 2005;77:325-35. (Pubitemid 40692871)
73. Yan YJ, Li Y, Lou B, Wu MP. Beneficial effects of ApoA-I on LPS-induced acute lung injury and endotoxemia in mice. Life Sci. 2006;79:210-5. (Pubitemid 43737069)
74. Pineiro M, Andres M, Iturralde M, Carmona S, Hirvonen J, Pyorala S, et al. ITIH4 (Inter-alpha-trypsin inhibitor heavy chain 4) is a new acute-phase potein isolated from cattle during experimental infection. Infection Immun. 2004;72:3777-82. (Pubitemid 38821889)
75. Discipio RG. The activation of the alternative pathway C3 convertase by human plasma kallikrein. Immunology. 1982;45:587-95.
76. Scharfstein J, Schmitz V, Svensjo E, Granato A, Monteiro AC. Kininogens coordinate adaptive immunity through the proteolytic release of bradykinin, an endogenous danger signal driving dendritic cell maturation. Scand J Immunol. 2007;66:128-36. (Pubitemid 47063208)
77. Eshraghi HR, Zeitlin IJ, Fitzpatrick JL, Ternent H, Logue D. The release of bradykinin in bovine mastitis. Life Sciences. 1999;64:1675-87. (Pubitemid 29185348)
78. Rosenberg ME, Girton R, Finkel D, Chmielewski D, Barrie AIII, Witte DP, et al. Apolipoprotein J/Clusterin prevents a progressive glomerulopathy of aging. Mol Cell Bio. 2002;22:1893-902. (Pubitemid 34175004)
79. McLaughlin L, Zhu G, Mistry M, Ley-Ebert C, Stuart WD, Florio CJ, et al. Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. J Clin Invest. 2000;106:1105-13.
80. Jones SE, Jomary C. Clusterin. Int J Biochem Cell Bio. 2002;34:427-31. (Pubitemid 34242756)
81. Sutra L, Poutrel B. Virulence factors involved in the pathogenesis of bovine intra-mammary infections due to Staphylococcus aureus. J Med Microbiol. 1994;40:79-89. (Pubitemid 24071727)
82. Dryla A, Prustomersky S, Gelbmann D, Hanner M, Bettinger E, Kocsis B, et al. Comparion of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin Diagn Lab Immunol. 2005;12:387-98. (Pubitemid 41175334)
83. Errington J, Bath J, Wu LJ. DNA transport in bacteria. Nat Rev Mol Cell Biol. 2001;2:538-44. (Pubitemid 33673404)
84. Cordwell SJ, Larsen MR, Cole RT, Walsh BJ. Comparative proteomics of Staphylococcus aureus and the response of methicillin-resistant and methicillin-sensitive strains to Triton X- Microbiol. 2002;148:2765-81.